Consultant, Gynaecologic Oncology and Gynaecology Laparoscopic and Robotic Surgery, Fortis Hospital, Yeshwanthpur, Bangalore
Part 3 of 13 in Overview of Gynaecological Cancers
Why India's HPV Vaccine Costs a Fifth of Gardasil
April 26, 2026
The single most powerful tool against cervical cancer is a vaccine that's been available since 2007. What's held back its impact in much of the world isn't the science, it's cost and awareness.
A fifth of the price
India's own quadrivalent HPV vaccine, introduced two years ago, sells for around 2,000 rupees, roughly 22 US dollars, against approximately 10,000 rupees, about 110 dollars, for Gardasil 9. Sixty percent of doses manufactured go into free government vaccination programmes, with the remaining 40 percent available through private and corporate hospitals.
What the vaccine actually prevents
Vaccination is roughly 90 percent effective against cervical cancer, 80 to 85 percent against vaginal, anal, vulvar and penile cancers, and 93 percent against oropharyngeal cancers. It reduces benign genital warts by 90 percent, and cuts recurrent respiratory papillomatosis in infants by more than 90 percent when the mother is vaccinated before delivery.
What Australia's programme shows is possible
Australia began vaccinating 14-year-old girls in its national immunisation programme, then added boys in 2013 once it recognised they were the ones spreading the virus into adulthood. Australia is now on track to become the first country to eliminate cervical cancer by 2030, and reportedly already has no new cases.
Why the same result hasn't followed everywhere
In large-population countries, the barrier isn't the vaccine's cost or effectiveness, it's scale and stigma. Not enough people attend awareness sessions, and the decision to make vaccination a national default has to be made collectively, by government, society and advocacy groups together. Dr. Punyashree notes doctors and NGOs in India are actively pushing to get the domestic vaccine into the national immunisation schedule for exactly this reason.
This guide is based on a live Jivo Masterclass — Dr. Punyashree R M taught doctors across Africa on April 26, 2026.
FROM THE LIVE Q&A
Dr. Kifle (Ethiopia)
How do we manage advanced stage cervical cancer?
Dr. Punyashree R M
If it's an advanced stage, stage 3 or 4, treatment is usually chemotherapy with radiation therapy. Squamous cell carcinomas are radiosensitive, and chemotherapy is given as a radiosensitiser to get a better response. If there's stage 4 disease with distant metastasis, systemic therapy is needed. Even after this, if there's residual disease and the patient's performance status is good, we'd still go back and remove the residual disease.
Book a Consultation with Dr. Punyashree R M
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669
Frequently Asked Questions
Which technique do you recommend for sentinel lymph node biopsy?▼
We use ICG dye and do the procedure robotically or laparoscopically with a 4K camera using the Firefly technique. We always open the retroperitoneal spaces first and get everything ready before injecting, because if there's bleeding during dissection after injecting, you won't be able to locate the sentinel node properly. If you're implementing this for the first time, do a pilot study of at least 25 cases each for endometrial and cervical cancer before using it as your standard method.
What are the post-operative morbidities associated with radical hysterectomy with lymph node dissection?▼
The most common complication is urinary issues, in about one or two out of every hundred patients we operate on, because we try carefully to identify and spare the inferior hypogastric nerve. Unlike axillary lymph node dissection, we don't see lymphoedema with the same frequency after pelvic lymph node dissection. We also follow the ERAS protocol, enhanced recovery after surgery, ambulating the patient the same day and starting oral intake within hours.
What are the preventive measures for PCOS?▼
PCOS is a lifestyle disease. If you correct the lifestyle, your hormones should be under control. We explain to patients what's causing the imbalance rather than putting them on hormonal pills upfront, and give them 3 to 4 months to work on diet, exercise, stress management and sleep, alongside antioxidant medications. 60 to 70 percent of our patients come back at the end of 3 months saying they're having regular cycles.
Is fertility-sparing treatment appropriate for ovarian cancer?▼
Fertility-sparing treatment is done only if the lady desires fertility, the disease is early, confined to one single ovary, with no peritoneal deposits and no malignant cells in the ascites. Even at stage 1B we'd do a diagnostic laparoscopy to check the other ovary, because imaging might miss small deposits. For germ cell tumours we always do fertility-sparing surgery because they're highly chemosensitive; for other tumours the decision has to be tailor-made.
How do we manage advanced stage cervical cancer?▼
If it's an advanced stage, stage 3 or 4, treatment is usually chemotherapy with radiation therapy. Squamous cell carcinomas are radiosensitive, and chemotherapy is given as a radiosensitiser to get a better response. If there's stage 4 disease with distant metastasis, systemic therapy is needed. Even after this, if there's residual disease and the patient's performance status is good, we'd still go back and remove the residual disease.
How much cheaper is India's HPV vaccine than Gardasil 9?▼
India's own quadrivalent HPV vaccine sells for around 2,000 rupees, roughly 22 US dollars, against approximately 10,000 rupees, about 110 dollars, for Gardasil 9, about a fifth of the price.
How effective is the HPV vaccine?▼
It's roughly 90 percent effective against cervical cancer, 80 to 85 percent against vaginal, anal, vulvar and penile cancers, and 93 percent against oropharyngeal cancers. It also reduces benign genital warts by 90 percent.
How did Australia make progress toward eliminating cervical cancer?▼
Australia began vaccinating 14-year-old girls in its national immunisation programme, then added boys in 2013 once it recognised they were spreading the virus into adulthood. It's now on track to become the first country to eliminate cervical cancer by 2030.
What's holding back wider HPV vaccine adoption in large-population countries?▼
Not the vaccine's cost or effectiveness, but scale and stigma: not enough people attend awareness sessions, and making vaccination a national default requires a collective decision by government, society, and advocacy groups.
In This Series: Overview of Gynaecological Cancers
- 1.Overview of Gynaecological Cancers
- 2.Cervical Cancer: The Only Cancer That Can Be Eliminated Worldwide
- 3.Why India's HPV Vaccine Costs a Fifth of Gardasil
- 4.Reading an Abnormal Pap Smear: When to Biopsy, When to Just Watch
- 5.Endometrial Cancer Is the Fastest-Rising Cancer in the World
- 6.The Molecular Subtypes That Now Decide Endometrial Cancer Treatment
- 7.When an IVF Patient's Endometrial Biopsy Comes Back Abnormal
- 8.Ovarian Cancer: Why It's Called the Silent Killer
- 9.Why Tubal Ligation Cuts Ovarian Cancer Risk by 64%
- 10.Fertility-Sparing Surgery for Ovarian Cancer: Who Actually Qualifies
- 11.Vulvar Cancer: A Diagnosis Many Women Delay Reporting
- 12.How Sentinel Lymph Node Mapping Actually Works
- 13.Why Nerve-Sparing Radical Hysterectomy Has Fewer Complications Than You'd Expect